Peetz Christopher sold MIRM
August 10, 2026 · Form 4 insider transaction
Peetz Christopher sold 2,300 shares of Mirum Pharmaceuticals, Inc. at $100.14 per share, a transaction worth $230.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,300
Price
$100.14
Total value
$230.3K
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 10, 2026
Filing dateAugust 11, 2026
Shares owned after194,309
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.; The weighted average sale price for the transaction reported was $100.14, and the range of prices were between $99.995 and $100.2425. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.